Hormone Resistant Prostate Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions:   Hormone-Resistant Prostate Cancer;   Stage IV Prostate AdenocarcinomaInterventions:   Drug: Cabazitaxel;   Drug: PrednisoneSponsors:   University of California, Davis;   SanofiNot yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2016 Category: Research Source Type: clinical trials

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions:   Hormone-Resistant Prostate Cancer;   Stage IV Prostate Adenocarcinoma Interventions:   Drug: Cabazitaxel;   Drug: Prednisone Sponsors:   University of California, Davis;   Sanofi Not yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2016 Category: Research Source Type: clinical trials

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
< b > Conditions < /b > :   Hormone-Resistant Prostate Cancer;   Stage IV Prostate Adenocarcinoma < br/ > < b > Interventions < /b > :   Drug: Cabazitaxel;   Drug: Prednisone < br/ > < b > Sponsors < /b > :   University of California, Davis;   Sanofi < br/ > < b > Not yet recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2016 Category: Research Source Type: clinical trials

Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions:   Hormone-Resistant Prostate Cancer;   Stage IV Prostate Adenocarcinoma Interventions:   Drug: Cabazitaxel;   Drug: Prednisone Sponsors:   University of California, Davis;   Sanofi Not yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2016 Category: Research Source Type: clinical trials

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions:   Metastatic Prostate Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate CancerInterventions:   Drug: Abiraterone Acetate;   Drug: Niclosamide;   Drug: PrednisoneSponsors:   University of California, Davis;   National Cancer Institute (NCI)Not yet recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2016 Category: Research Source Type: clinical trials